Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research focused on Docetaxel and Escitalopram, with related work in Breast cancer, Confidence interval, Carboplatin. Notable publications include 'Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study', 'Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis', and 'Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative , early‐stage breast cancer ( NeoCART ): Results from a...'.
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study
Transcutaneous electrical cranial‐auricular acupoint stimulation versus escitalopram for mild‐to‐moderate depression: An assessor‐blinded, randomized, non‐inferiority trial
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in <scp>triple‐negative</scp>, <scp>early‐stage</scp> breast cancer (<scp>NeoCART</scp>): Results from a multicenter, randomized controlled, <scp>open‐label</scp> phase <scp>II</scp> trial
Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database
Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis